Lancet Global Health

Papers
(The H4-Index of Lancet Global Health is 73. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Bringing home manufacturing of medical products1301
Preventing pellagra during isoniazid preventive treatment674
Racism and health: the need for urgent action491
Periconceptional diet and the risk of gestational diabetes in south Indian women: findings from the BAngalore Nutrition Gestational diabetes LiFEstyle Study (BANGLES)441
The future of the International Health Regulations416
Queering global health: a feminist and lesbian, gay, and bisexual perspective – Authors' reply411
The cause of nodding syndrome remains unknown398
Enhancing global cancer care for sexual and gender minority populations: regional perspectives and global implications394
The pneumonia challenge: time to end the global neglect327
Correction to Lancet Glob Health 2024; published online Sept 23. https://doi.org/10.1016/S2214-109X(24)00320-6302
Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial272
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys260
Implementation of the 7-1-7 target for detection, notification, and response to public health threats in five countries: a retrospective, observational study235
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019226
Global patterns and trends in Kaposi sarcoma incidence: a population-based study212
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study212
Patient-level and system-level determinants of stroke fatality across 16 large hospitals in Ghana and Nigeria: a prospective cohort study210
The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis209
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study202
Resolving the CD4-testing crisis to help end AIDS-related deaths199
Indonesia's first nationwide health screening programme189
Is now the time for revisiting supplements for pregnant women?189
The road to malaria elimination: why a robust surveillance system is imperative186
Expanding access to long-acting HIV therapy in low-income and middle-income countries185
Safe scale-up of simulation-based training for minimally invasive surgery184
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income cou183
Mpox vaccination strategies in DR Congo179
C-reactive protein: another addition to our armamentarium against tuberculosis?172
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled tr166
The drug drought in maternal health: an ongoing predicament160
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platfor155
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study142
The health status of Indonesia's provinces: the double burden of diseases and inequality gap133
Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social–emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study133
Influenza vaccination in failing hearts129
Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study128
Outcomes of rheumatic fever in Uganda: a prospective cohort study126
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial125
Physical inactivity: another casualty of climate change125
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis122
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical m119
Using verbal autopsy to enhance mortality surveillance114
Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis113
Payment in arrears: a global health inequity that must be corrected106
Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine106
Lessons for future implementation of the E-MOTIVE bundle104
Experiences of an Israeli hospital in the management of repatriated civilian hostages103
Quality of inpatient paediatric and newborn care in district hospitals: WHO indicators, measurement, and improvement101
Sustainability of a 12-month lifestyle intervention delivered by community health workers in reducing blood pressure in Nepal: 5-year follow-up of the COBIN open-label, cluster randomised trial101
Advancing maternal and perinatal health through clinical trials: key insights from a WHO global consultation100
Infertility—why the silence?99
Aedes albopictus invasion across Africa: the time is now for cross-country collaboration and control98
Switching antibiotic therapy from injectable to oral to optimise the duration of inpatient care for young infants presenting with moderate-mortality-risk signs of possible serious bacterial infection:96
Avoidable deaths through the primary prevention, early detection, and curative treatment of cancer worldwide: a population-based study95
TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden91
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 202690
Pregnancy in people who have survived Ebola virus disease88
Using theory to understand how interventions work and inform future implementation88
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study88
Mpox: evidence for strengthening and sustaining global surveillance84
How to DREAMM and end HIV-related deaths83
Addressing the social inequities of vaccination: an imperative to close the gap83
Locally validated biomarker cutoffs should inform micronutrient deficiency burdens – Authors' reply82
Cervical cancer elimination: actions needed in the COVID-19 era80
Correction to Lancet Glob Health 2023; 11: e1978–8579
Correction to Lancet Glob Health 2022; 10: e1443–5279
Improving access to liposomal amphotericin B worldwide78
Correction to Lancet Glob Health 2015; 3: e19678
Correction to Lancet Glob Health 2025; 13: e2013–2678
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all78
Highlighting the need for investment and innovation in ART retention interventions75
Uncertainty in key population size estimates in sub-Saharan Africa75
Beyond malaria: can intermittent preventive treatment with sulphadoxine-pyrimethamine reduce the number of small vulnerable newborns globally?74
0.1312301158905